Php162 - Licenced Orphan Medicines Expenditure in Turkey

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.1056
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Php109 - Cost of Unlicenced and Orphan Medicines in Turkey, Kazakhstan and Poland

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Low Availability of Orphan Medicines in Serbia

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Orphan Medicines: The High Cost of Hope

Prescriber
Pharmacology
2018English

Prescribed Medicines: Findings From the National Medical Care Expenditure Survey.

American Journal of Public Health
EnvironmentalPublic HealthOccupational Health
1983English

Erratum To: Establishing Medical Plausibility in the Context of Orphan Medicines Designation in the European Union

Orphanet Journal of Rare Diseases
MedicineGeneticsPharmacology
2015English

Discount Distribution Analysis of Original Medicines Which Has No Generics in Turkey

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

Forecasting for Healthcare Expenditure of Turkey Covering the Years of 2018-2050

Gümüşhane Üniversitesi Sağlık Bilimleri Dergisi
2020English

Psy60 - Orphan Versus Ultra-Orphan Drugs Prices in England

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

The Causes of Aging and Relationship Between Aging and Health Expenditure: An Econometric Causality Analysis for Turkey

International Journal of Health Planning and Management
MedicineHealth Policy
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy